Succinobucol’s New Coat — Conjugation with Steroids to Alter Its Drug Effect and Bioavailability
Authors:
- Ondřej JurčekOJOndřej Jurček
- Satu IkonenSISatu Ikonen
- Lucie BuřičováLBLucie Buřičová
- Martina WimmerováMWMartina Wimmerová
- Zdeněk WimmerZdeněk Wimmer
- Pavel DrašarPavel Drašar
- Jan HorníčekJHJan Horníček
- Adéla GalandákováAGAdéla Galandáková
- Jitka UlrichováJUJitka Ulrichová
- Erkki T. KolehmainenEKErkki T. Kolehmainen
Open Access
- 10 November 2011
- Vol. 16 (11) , 9404-9420
Abstract
Synthesis, detailed structural characterization (X-ray, NMR, MS, IR, elemental analysis), and studies of toxicity, antioxidant activity and bioavailability of unique potent anti-atherosclerotic succinobucol-steroid conjugates are reported. The conjugates consist of, on one side, the therapeutically important drug succinobucol ([4-{2,6-di-tert-butyl-4-[(1-{[3-tert-butyl-4-hydroxy-5-(propan-2-yl)phenyl]sulfanyl}ethyl)sulfanyl]phenoxy}-4-oxo-butanoic acid]) possessing an antioxidant and anti-inflammatory activity, and on the other side, plant stanol/sterols (stigmastanol, β-sitosterol and stigmasterol) possessing an ability to lower the blood cholesterol level. A cholesterol-succinobucol prodrug was also prepared in order to enhance the absorption of succinobucol through the intestinal membrane into the organism and to target the drug into the place of lipid metabolism—The enterohepatic circulation system. Their low toxicity towards mice fibroblasts at maximal concentrations, their antioxidant activity, comparable or even higher than that of ascorbic acid as determined by direct quenching of the DPPH radical, and their potential for significantly altering total and LDL cholesterol levels, suggest that these conjugates merit further studies in the treatment of cardiovascular or other related diseases. A brief discussion of succinobucol’s ability to quench the radicals, supported with a computational model of the electrostatic potential mapped on the electron density surface of the drug, is also presented.Keywords
This publication has 34 references indexed in Scilit:
- AGI-1067, a novel antioxidant and anti-inflammatory agent, enhances insulin release and protects mouse isletsMolecular and Cellular Endocrinology, 2010
- Molecular mechanisms underlying the antiatherosclerotic and antidiabetic effects of probucol, succinobucol, and other probucol analoguesCurrent Opinion in Lipidology, 2009
- Succinobucol: review of the metabolic, antiplatelet and cardiovascular effectsExpert Opinion on Investigational Drugs, 2009
- Current and emerging paradigms in the therapeutic management of atherosclerosisExpert Opinion on Therapeutic Targets, 2008
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Cholesterol and Plant Sterol Absorption: Recent InsightsThe American Journal of Cardiology, 2005
- Dietary phytosterols: A review of metabolism, benefits and side effectsLife Sciences, 1995
- The MTT Tetrazolium Salt Assay Scrutinized: How to Use this Assay Reliably to Measure Metabolie Activity of Cell Cultures in vitro for the Assessment of Growth Characteristics, IC50-Values and Cell SurvivalClinical Chemistry and Laboratory Medicine (CCLM), 1995
- Probucol scavenged 1,1-diphenyl-2-picrylhydrazyl radicals and inhibited formation of thiobarbituric acid reactive substancesFree Radical Biology and Medicine, 1994
- Simple Method for the Esterification of Carboxylic AcidsAngewandte Chemie International Edition, 1978